Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union (PERFORM)

Start date: Jan 1, 2016, End date: Dec 31, 2020,

The management of febrile patients is one of the most common and important problems facing healthcare providers. Distinction between bacterial infections and trivial viral infection on clinical grounds is unreliable, and as a result innumerable patients worldwide undergo hospitalization, invasive investigation and are treated with antibiotics for presumed bacterial infection when, in fact, they ar ...
Read Project

 19

 FINISHED 

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates (EHVA)

Start date: Jan 1, 2016, End date: Dec 31, 2020,

Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. There is an urgent need to develop better vaccines and tools predictive of immunogenicity and of correlates of protection at early stage of vaccine development to mitigate the risks of failure. To address these complex and challenging scientific issues, the Eur ...
Read Project

 43

 FINISHED 

Sharing Cities (SHAR-LLM)

Start date: Jan 1, 2016, End date: Dec 31, 2020,

Sharing Cities has four key objectives. 1) To achieve scale in the European smart cities market by proving that properly designed smart city solutions, based around common needs, can be integrated in complex urban environments. This will be done in a way that exhibits their true potential and allows for the significant scale-up and consequent increase in social, economic and environmental value. ...
Read Project

 36

 FINISHED 

European AIDS Vaccine Initiative 2020 (EAVI2020)

Start date: Nov 1, 2015, End date: Oct 31, 2020,

HIV-1 is responsible for a global pandemic of 35 million people, and continues to spread at a rate of >2 million new infections/year. It is widely acknowledged that a protective vaccine would be the most effective means to reduce HIV-1 spread and ultimately eliminate the pandemic, while a therapeutic vaccine may help mitigate the clinical course of disease and lead to strategies of viral eradicati ...
Read Project

 27

 FINISHED 

Family-based intervention to improve healthy lifestyle and prevent Type 2 Diabetes amongst South Asians with central obesity and prediabetes (iHealth-T2D)

Start date: Jan 1, 2015, End date: Dec 31, 2019,

South Asians, who represent one-quarter of the world’s population, are at high risk of type-2 diabetes (T2D). Intensive lifestyle modification (healthy diet and physical activity) is effective at preventing T2D amongst South Asians with impaired glucose tolerance, but this approach is limited by high-cost, poor scalability and low impact on T2D burden. We will complete a cluster-randomised clinica ...
Read Project

 13

 FINISHED 

Holistic Approach of Spray Injection through a Generalized Multi-phase Framework (HAoS)

Start date: Nov 1, 2015, End date: Oct 31, 2019,

Development of fuel injection equipment (FIE) able to reduce pollutant emissions from liquid-fueled transportation and power generation systems is a top industrial priority in order to meet the forthcoming EU 2020 emission legislations. However, design of new FIE is currently constrained by the incomplete physical understanding of complex micro-scale processes, such as in-nozzle cavitation, primar ...
Read Project

 10

 FINISHED 

THERMOS (Thermal Energy Resource Modelling and Optimisation System) (THERMOS)

Start date: Oct 1, 2016, End date: Sep 30, 2019,

THERMOS (Thermal Energy Resource Modelling and Optimisation System) will develop the methods, data, and tools to enable public authorities and other stakeholders to undertake more sophisticated thermal energy system planning far more rapidly and cheaply than they can today. This will amplify and accelerate the development of new low carbon heating and cooling systems across Europe, and enable fast ...
Read Project

 16

 FINISHED 

The Developing Human Connectome Project (dHCP)

Start date: Sep 1, 2013, End date: Aug 31, 2019,

Few advances in neuroscience could have as much impact as a precise global description of human brain connectivity and its variability. Understanding this ‘connectome’ in detail will provide insights into fundamental neural processes and intractable neuropsychiatric diseases.The connectome can be studied at millimetre scale in humans by neuroimaging, particularly diffusion and functional connectiv ...
Read Project

 4

 FINISHED 

DE-ENIGMA: Multi-Modal Human-Robot Interaction for Teaching and Expanding Social Imagination in Autistic Children (DE-ENIGMA)

Start date: Feb 1, 2016, End date: Jul 31, 2019,

Autism Spectrum Conditions (ASC, frequently defined as ASD - Autism Spectrum Disorders) are neurodevelopmental conditions, characterized by social communication difficulties and restricted and repetitive behaviour patterns. There are over 5 million people with autism in Europe – around 1 in every 100 people, affecting lives of over 20 million people each day. Alongside their difficulties, individu ...
Read Project

 9

 FINISHED 

Lifecourse biological pathways underlying social differences in healthy ageing (LIFEPATH)

Start date: May 1, 2015, End date: Apr 30, 2019,

"The dramatic differentials in healthy ageing, quality of life and life expectancy between individuals of different socioeconomic groups, is a major societal challenge facing Europe. The overarching aim of the LIFEPATH project is to understand the determinants of diverging ageing pathways among individuals belonging to different socio-economic groups. This will be achieved via an original study de ...
Read Project

 18

 FINISHED 

Understanding the dynamic determinants of glucose homeostasis and social capability to promote Healthy and active aging (DYNAHEALTH)

Start date: Apr 1, 2015, End date: Mar 31, 2019,

The Gluco-Psychosocial Axis (GPA) concerns the interplay of factors determining glucose metabolism and insulin sensitivity and the neuroendocrine response resulting from exposure to psychosocial stress. A sub-optimal GPA influences the development of type 2 diabetes and related impairments with varying degrees of interplay between genetics and early growth (particularly adiposity and cognitive fun ...
Read Project

 14

 FINISHED 

eNHANCE - intention based enhancement of reaching and grasping in physically disabled people - personalized to maximize user performance (eNHANCE)

Start date: Feb 1, 2015, End date: Jan 31, 2019,

The eNHANCE project key objective is to symbiotically mechanically support and motivate people with motor impairments resulting from muscular or neural degeneration (e.g. stroke) to perform complex daily life tasks. Our system aims to assist the user in performing their daily-life interaction with the environment through an intelligent multi-modal adaptive interface controlled by a high performanc ...
Read Project

 11

 FINISHED 

Neuropathic pain: biomarkers and druggable targets within the endogenous analgesia system (NEUROPAIN)

Start date: Jan 1, 2014, End date: Dec 31, 2018,

Neuropathic pain has a high incidence in Europe and often affects the patient’s emotional balance and quality of life. Recent meta-analyses have shown that conventional analgesic drugs are not sufficiently effective in these patients and are limited by serious side effects. The search for new analgesics is extremely difficult despite identification of several new potential targets and enormous inv ...
Read Project

 12

 FINISHED 

Computational and functional annotation of genomic elements during development of the model vertebrate zebrafish (ZENCODE)

Start date: Jan 1, 2015, End date: Dec 31, 2018,

The recent explosion of next generation sequencing (NGS) data has caught Europe unprepared and led to a critical shortage of computational biology expertise. As NGS methods are expected to become pervasive from basic science to personalised medicine there is an urgent need for highly skilled young scientists trained in both computational biology and experimental wet lab biology. Our network addres ...
Read Project

 11

 FINISHED 

TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBVAC2020)

Start date: Jan 1, 2015, End date: Dec 31, 2018,

The TBVAC2020 proposal builds on the highly successful and long-standing collaborations in subsequent EC-FP5-, FP6- and FP7-funded TB vaccine and biomarker projects, but also brings in a large number of new key partners from excellent laboratories from Europe, USA, Asia, Africa and Australia, many of which are global leaders in the TB field. This was initiated by launching an open call for Express ...
Read Project

 49

 FINISHED 

Models of Child Health Appraised (MOCHA)

Start date: Jun 1, 2015, End date: Nov 30, 2018,

Children’s health affects the future of Europe – children are citizens, future workers, parents and carers. Children are dependent on society to provide effective health services (UN Convention on the Rights of the Child). Models of child primary health care vary widely across Europe based on two broad alternatives (primary care paediatricians or generic family doctors), and a variety of models of ...
Read Project

 20

 FINISHED 

Targets and biomarkers for antiepileptogenesis (EPITARGET)

Start date: Nov 1, 2013, End date: Oct 31, 2018,

Epilepsy is a devastating condition affecting over 50 million people worldwide. This multidisciplinary project is focused on the process leading to epilepsy, epileptogenesis, in adults. Our main hypothesis is that there are combinations of various causes, acting in parallel and/or in succession, that lead to epileptogenesis and development of seizures. Our central premise and vision is that a comb ...
Read Project

 20

 FINISHED 

Hepatic and Cardiac Toxicity Systems modelling (HECATOS)

Start date: Oct 1, 2013, End date: Sep 30, 2018,

HeCaToS aims at developing integrative in silico tools for predicting human liver and heart toxicity. The objective is to develop an integrated modeling framework, by combining advances in computational chemistry and systems toxicology, for modelling toxic perturbations in liver and heart across multiple scales. This framework will include vertical integrations of representations from drug(metabol ...
Read Project

 14

 FINISHED 

Human Brain Project Specific Grant Agreement 1 (HBP SGA1)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

Understanding the human brain is one of the greatest scientific challenges of our time. Such an understanding can provide profound insights into our humanity, leading to fundamentally new computing technologies, and transforming the diagnosis and treatment of brain disorders. Modern ICT brings this prospect within reach. The HBP Flagship Initiative (HBP) thus proposes a unique strategy that uses I ...
Read Project

 126

 FINISHED 

Graphene-based disruptive technologies (GrapheneCore1)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

This project is the second in the series of EC-financed parts of the Graphene Flagship. The Graphene Flagship is a 10 year research and innovation endeavour with a total project cost of 1,000,000,000 euros, funded jointly by the European Commission and member states and associated countries. The first part of the Flagship was a 30-month Collaborative Project, Coordination and Support Action (CP-CS ...
Read Project

 158

 FINISHED 

How force regulates cell function: a molecular and cellular outlook (ForceRegulation)

Start date: Mar 1, 2012, End date: Feb 28, 2018,

Force is ubiquitous in nature and physical stimuli are crucial for cell function. How cells process forces determines key physiological processes such as cell growth and differentiation, in which cells divide or differentiate according to the chemical and physical cues cells receive from the extracellular matrix. Physical stimuli have also been involved in the development of pathological processes ...
Read Project

 3

 FINISHED 

Preparing for Extreme And Rare events in coastaL regions (PEARL)

Start date: Jan 1, 2014, End date: Dec 31, 2017,

"Coastal floods are one of the most dangerous and harmful natural hazards affecting urban areas adjacent to shorelines. Rapid urbanisation combined with climate change and poor governance means a significant increase in the risk of local surface flooding coinciding with high water levels in rivers and high tide or storm surges from the sea, posing a greater risk of devastation to coastal communiti ...
Read Project

 26

 FINISHED 

QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy (QUIC-CONCEPT)

Start date: Sep 1, 2011, End date: Dec 31, 2017,

The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours in patients in realistic trials. Our vision for January 2016 is that drug developers can incorporate these IBs for decision- ...
Read Project

 26

 FINISHED 

Stem-cell based therapy for kidney repair (STELLAR)

Start date: Nov 1, 2012, End date: Oct 31, 2017,

Chronic kidney disease (CKD) affects 8% of the European population and ultimately results in renal failure due to progressive fibrosis. CDK carries a high mortality risk and the number of affected people rises, increasing the demand on renal replacement therapies while the number of available donor organs stays stable.The STELLAR consortium proposes to develop an alternative to renal replacement ...
Read Project

 15

 FINISHED 

PHYSICAL ACTIVITY THROUGH SUSTAINABLE TRANSPORT APPROACHES (PASTA)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

This project focuses on the systematic promotion and facilitation of active mobility (AM) (i.e. walking and cycling including the combination with public transport use) as an innovative approach to integrate physical activity (PA) into individuals’ everyday lives. In contrast to sports or exercise, AM requires less time and motivation, since AM provides both convenience as a mode of transport, and ...
Read Project

 18

 FINISHED 

Advanced Immunization Technologies (ADITEC)

Start date: Oct 1, 2011, End date: Sep 30, 2017,

Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious diseases we need to fully exploit the potential of the human immune system. Progress in science and technology makes it possible to achieve what was previously deemed impossible. The scope of this project is to produce knowledge necessary to develop novel and ...
Read Project

 53

 FINISHED 

FREVUE VALIDATING FREIGHT ELECTRIC VEHICLES IN URBAN EUROPE (FREVUE)

Start date: Mar 15, 2013, End date: Sep 14, 2017,

Eight of Europe’s largest cities, will demonstrate that electric vehicles operating “last mile” freight movements in urban centres can offer significant and achievable decarbonisation of the European transport system. Demonstrators will be deployed in Amsterdam, Lisbon, London, Madrid, Milan, Oslo, Rotterdam and Stockholm. The demonstrators have been designed to ensure FREVUE covers the breadth of ...
Read Project

 30

 FINISHED 

Enhanced exposure assessment and omic profiling for high priority environmental exposures in Europe (EXPOSOMICS)

Start date: Nov 1, 2012, End date: Apr 30, 2017,

This project aims to predict individual disease risk related to the environment, by characterizing the external and internal exposome for common exposures (air and drinking water contaminants) during critical periods of life, including in utero. A large amount of health data is now available from longitudinal cohorts in both children and adults, with detailed information on risk factors, confounde ...
Read Project

 15

 FINISHED 

Biomaterials for Tracheal Replacement in Age-related Cancer via a Humanly Engineered Airway (BIOtrachea)

Start date: Apr 1, 2012, End date: Mar 31, 2017,

Age-related cancers, especially of the trachea, are neoplastic lesions that significantly impact upon the lives of thousands of European patients each year. Unfortunately, most present with inoperable lesions for which median survival is less than 12 months. Based on our previous clinically successful experiences with in vivo completely tissue engineered tracheal replacement in benign tracheal dis ...
Read Project

 13

 FINISHED 

Deciphering the ubiquitin code of the TNF receptor signalling complex and its functional role in inflammation and immunity (UB-DECODED)

Start date: Apr 1, 2012, End date: Mar 31, 2017,

Tumour necrosis factor (TNF) is a cytokine with important functions in inflammation, immunity and cancer. Signalling processes mediated by ubiquitin are crucial for TNF signalling. The seven lysine (K) residues and the N-terminus of ubiquitin can be used to form ubiquitin chains. Employing a method newly developed in our laboratory we identified the presence of four of these ubiquitin chain linkag ...
Read Project

 3

 FINISHED 

Combined Efficient Large Scale Integrated Urban Systems (CELSIUS)

Start date: Apr 1, 2013, End date: Mar 31, 2017,

...tive organizations, with track records both in creating technically and economically innovative demonstrators, as well as in understanding and overcoming the barriers for large scale deployment (e.g. Imperial College (UK), SP (S), TU Delft (NL), Cologne University of Applied Sciences (D), D’Appalonia (IT), LSE (UK)).CELSIUS has eight work packages targeting on the successful deployment of the 13 n ...
Read Project

 21

 FINISHED 

VPH Dementia Research Enabled by IT (VPH-DARE@IT)

Start date: Apr 1, 2013, End date: Mar 31, 2017,

The DementiA Research Enabled by IT project responds to the European Parliament's 2011 resolution for a European Initiative on Alzheimer's disease and other dementias, and the EU Year of the Brain 2014 Initiative. It delivers the first patient-specific predictive models for early differential diagnosis of dementias and their evolution. Its mechanistic/phenomenological models of the ageing brain ac ...
Read Project

 22

 FINISHED 

Integrated Approaches to Food Allergen and Allergy Risk Management (IFAAM)

Start date: Mar 1, 2013, End date: Feb 28, 2017,

Up to 20 million European citizens suffer from food allergy. However management of both food allergy (by patients and health practitioners) and allergens (by industry) is thwarted by lack of evidence to either prevent food allergy developing or protect adequately those who are already allergic. iFAAM will develop evidence-based approaches and tools for MANAGEMENT of ALLERGENS in FOOD and integrate ...
Read Project

 46

 FINISHED 

Co-morbidity in relation to Aids (COBRA)

Start date: Mar 1, 2013, End date: Feb 28, 2017,

Persons with HIV on combination antiretroviral therapy (cART) are at increased risk of the premature development of age-associated non-communicable comorbidities (AANCC), including cardiovascular, chronic kidney, liver and pulmonary disease, diabetes mellitus, osteoporosis, non-AIDS associated malignancies, and neurocognitive impairment. It has therefore been hypothesised that such individuals, de ...
Read Project

 12

 FINISHED 

Brazilian-European partnership in Dynamical Systems (BREUDS)

Start date: Jan 1, 2013, End date: Dec 31, 2016,

"This is a project for a partnership between leading Brazilian and European research groups in dynamical systems, a prominent subject in mathematics. An extensive consortium of European and Brazilian institutions will collaborate to provide world leading critical mass and support for research on the very forefront of the field. Work Packages reflect parallel priorities in the research. Transfer o ...
Read Project

 22

 FINISHED 

Biomarkers For Enhanced Vaccine Safety (BIOVACSAFE)

Start date: Mar 1, 2012, End date: Dec 31, 2016,

BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised into focused Activity Cores to generate knowledge and tools to benchmark licensed vaccine reactogenicity, and create practical and generalizable guidelines and techniques to enhance immunosafety of novel vaccines from pre-development to post-marketing surveil ...
Read Project

 24

 FINISHED 

Network Topology Complements Genome as a Source of Biological Information (BIONET)

Start date: Jan 1, 2012, End date: Dec 31, 2016,

...data and hence complement biological information that can be extracted from sequence. I propose to exploit these new techniques for biological applications in collaboration with experimentalists at Imperial College London: 1. aligning biological networks of species whose genomes are closely related, but that have very different phenotypes, in order to uncover systems-level factors that contribut ...
Read Project

 3

 FINISHED 

Collaborative Network for Training in Electronic Skin Technology (CONTEST)

Start date: Oct 1, 2012, End date: Sep 30, 2016,

"Future electronic systems will be bendable and conformable. They will be wearable, disposable, and ubiquitous. CONTEST will train young researchers in the fast expanding field of flexible and large area electronics with emphasis on “wearable” devices.Training will be implemented through well-defined work packages covering critical aspects of flexible electronics, converging towards an electronica ...
Read Project

 7

 FINISHED 

Promoting the Scientific Exploration of Computational Creativity (PROSECCO)

Start date: Mar 1, 2013, End date: Aug 31, 2016,

Creativity is a long-cherished and widely-studied aspect of human behavior that allows us to re-invent the familiar and to imagine the new. Computational Creativity (CC) is a recent but burgeoning area of creativity research that brings together academics and practitioners from diverse disciplines, genres and modalities, to explore the potential of computers to be autonomously creative or to colla ...
Read Project

 8

 FINISHED 

NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE (TRANSEURO)

Start date: Jan 1, 2010, End date: Jun 30, 2016,

There are currently no cures for Parkinson's disease (PD) but one of the most effective reparative therapies in patients to date has been with allotransplants of dopamine (DA) neuroblasts obtained from fetal ventral mesencephalic (VM) tissue. However, this cell transplantation approach has given inconsistent results, with some patients doing extremely well and coming off anti-PD medication for yea ...
Read Project

 15